Clinical Trial Update: Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics [Phase 1]

View source ↗

Summary

Phase 1 trial results provide safety and pharmacodynamic data on repeated injections and escalating doses of UPB-101 in adults with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• UPB-101

Snippet

Sponsor: Upstream Bio Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2025-01-03